INVITATION TO 8TH WORLD CANCER CONGRESS - 2024
Arjyopa Healthcare and Cancer Healer Center welcomes you to attend the 8th World Cancer Congress - 2024 during March 18th - 20th, 2024 at JNU Convention Centre, Jawaharlal Nehru University, New Delhi, India. We cordially invite all the participants interested in sharing their knowledge and research in the arena of Oncology and Cancer Research. From feedback received, the previous Congresses 2016, 2017, 2018, 2019, 2020, 2021, 2022 resulted in fruitful collaborations and rewarding experiences for the delegates who left the events with concrete tools and solutions that helped them enhance their work practice and impact. As hosts, we already feel very excited to create the same energetic and inspiring atmosphere during the Congress week, adding local flavors and new perspectives such as the role of complementary treatment in cancer to the programme.
The 8th World Cancer Congress - 2024 will also explore the new ideas and concepts on global scale and the topics on Cancer Biology & Genetics, Yoga and Naturopathy, Ayurveda and Cancer, Organ-Defined Cancers, Oncology: Sub-Specialities, Radiation Oncology, Surgical Oncology, Cancer & Stem Cell Therapy, Precision Cancer Medicine & Oncology, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer: Psychological & Social Aspects. The 8th World Cancer Congress – 2024 will also focus on Cancer Stem Cells, Cancer Basic & Applied Research Tumor, Anti Cancer Drug Discovery, Clinical Oncology and Personalized Cancer Medicine. It will give us novel insight into the complexity of the connections between Cancer and Metabolism &Immune Checkpoints, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer: Psychological & Social Aspects, to deliver an outstanding program with the right balance of clinical relevance, which covers the entire spectrum of practice issues in Cancer Research and Treatments.
Thus, the urgent need to mobilize our efforts, promote cancer advocacy more efficiently and develop effective national policies and plans for prevention, early detection, care and support.
We look forward to the honor of welcoming you at New Delhi during the conference.
LETTER FROM THE MINISTRY
CHAIRMAN MESSAGE
On behalf of the Organizing Committee, it is my pleasure to invite all of the great scientists, academicians, young researchers, Business delegates and students from all over the world to attend the 8th World Cancer Congress – 2024 which has been scheduled from March 18th – 20th, 2024. The 8th World Cancer Congress – 2024 will be hosted at JNU Convention Centre, Jawaharlal Nehru University, New Delhi, India.
Cancer is the second leading cause of death worldwide. It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. This year the world cancer congress - 2024 will also focused on swadashi treatment on cancer like AYURVEDA, Homeopathy Approach towards cancer treatment, Yoga and Naturopathy, UNANI medicine etc.
WCC2024 will be the best platform for all the Oncologists, Hematologists, Ayush Practioner, Cancer Researcher, Research scholars, Students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life.
We look forward to the honor of welcoming you at the summit.
With Warm Regards
Padma Shri Dr. Kodaganur S. Gopinath
Consultant Surgical Oncologist & Director
HCG, India
8th World Cancer Congress - 2024 | New Delhi
KEYNOTE SPEAKERS & FACULTY
Padma Bhushan Dr. Suresh H Advani
Senior Oncologist,
Jaslok Hospital, INDIA
Padma Bhushan Dr. G P Talwar
Former Director,
National Institute of Immunology, INDIA
Padma Shri Dr. Anil D'Cruz
Director, Oncology,
Apollo Hospital, INDIA
Padma Shri Dr. Lalit Kumar
Prof & HOD, Dept of Medical Oncology,
AIIMS, INDIA
Padma Shri Dr. Ashok Gupta
Senior Plastic Surgeon,
BHIMS, INDIA
Dr. G. K. Rath
Chief-Radiation Oncologist,
AIIMS, INDIA
Padma Shri Dr. Ramakant K. Deshpande
Senior Oncologist & Director,
Asian Cancer Institute, INDIA
Padma Shri Dr. Kamini Rao
Senior Gynaec-Oncologist,
MILANN, INDIA
Padma Shri Dr. J. K. Singh
Senior Oncologist & Director,
SS Hospitals and Research Centre, INDIA
Dr. Sanjay Sharma
Director & Senior Oncologist,
ACI-Cumballa Hill Hospital, INDIA
Dr. Raghavendra Rao
Director-CCRYN,
Ministry of AYUSH, INDIA
Dr. Tarang Krishna
Director,
Cancer Healer Center, INDIA
Dr. Deepika Krishna
Director,
Cancer Healer Center, INDIA
Dr. Shyam Aggarwal
Senior Medical Oncologist,
Sir Ganga Ram Hospital, INDIA
Dr. Ashish Kumar
Professor & Senior Consultant,
Sir Ganga Ram Hospital, INDIA
Dr. Ashok Sharma
Additional Professor,
AIIMS/NCI-Jhajjar, INDIA
Dr. Birandra K Sinha
Senior Scientist,
NIH, USA
Prof. Debu Tripathi
Dept. of Breast Medical Oncology
MD Anderson Cancer Center, USA,
Dr. Shreyash Kumar Patel
Dept. of Sarcoma Medical Oncology,
MD Anderson Cancer Center, USA
Prof. Umesh K Reddy
Dept. of Genetics & Genomics,
West Virginia State University, USA
Prof. Ashutosh Tewari
Dept. of Urology,
Icahn School of Medicine, USA
Dr. Jagadananda Ghosh
Senior Cancer Researcher,
Henry Ford Health, USA
Dr. Sikander Ailawadhi
Professor, Dept. of Oncology,
MAYO Clinic, USA
Dr. Philip Agop Philip
Professor, Dept of Oncology and Pharmacology
Wayne State University, USA
Prof. Raghu Sinha
Dept of Biochemistry and Molecular Biology,
Penn State Cancer Institute, USA
Dr. Sandip Saha
Department of Medicine,
Jacobs School of Medicine & Biomedical Sciences, USA
Dr. Hari K Koul
Professor, Dept. of Urology and Cancer Center
LSU-LCMC Cancer Center, USA
Prof. Shailesh Singh
Professor, Dept. of Microbiology, Biochemistry & Immunology
Morehouse School of Medicine, USA
Prof. Hem D. Shukla
Dept. of Radiation Oncology,
University of Maryland, USA
Prof. Arvind Rao
Department of Computational Medicine & Bioinformatics
University of Michigan, USA
Prof. Jamboor K. Vishwanatha
Regents Professor and Vice President,
University of North Texas Health Science Center, USA
Prof. Sushanta Banerjee
Dept. of Pathology and Lab Medicine,
University of Kansas Medical Center, USA
Dr. Asfar Sohail Azmi
Associate Professor, Department of Oncology,
Wayne State University, USA
Prof. Ravinder Mamtani
Vice Dean, Population Health and Lifestyle Medicine,
Weill Cornell Medicine,Qatar
Prof. Pradeep Tyagi
Associate Professor, Department of Urology,
University of Pittsburgh, USA
Dr. A K Dewan
Director, Dept. of Surgical Oncology,
Rajiv Gandhi Cancer Institute and Research Centre, INDIA
Prof. Pankaj Kumar Singh
Prof. and Founding Chairman, Dept. of Oncology Science,
OUH Stephenson Cancer Center, USA
Prof. Manjeet K. Rao
Deputy Director, Greehey Children’s Cancer Research Institute
UT Health San Antonio, USA
Prof. Rajagopal Ramesh
Professor and Associate Director, Dept of Pathology
OU College of Medicine, USA
Dr. Swarupa Mitra
Director and Unit Head, Dept. of Radiation Oncology,
FMRI, INDIA
Prof. Rajvir Dahiya
Professor, Dept. of Uro-Oncology,
UCSF, USA
Prof. Keshav K Singh
Professor, Dept of Genetic Research,
The University of Alabama, USA
Prof. Lavanya Vishwanatha
Research Enterprise Solutions Director,
UNTHSC, USA
Dr. Rasleen K. Saluja
Department of Pathology,
University of Illinois, USA
Prof. Amitava Adhikary
Dept. of Physical Chemistry, Radiation Chemistry of Biomolecules
Oakland University, USA
Dr. Surendra Shukla
Department of Oncology Science
OU Health Stephenson Cancer Center, USA
Prof. Ajit K Saxena
Prof & HOD, Dept. of Pathology and Lab Medicine,
AIIMS, INDIA
Prof. Sebastian Schoppmann
Head, Upper-GI-Service, Dept. of General Surgery
Medical University of Vienna, AUSTRIA
Dr. Hemant Sarin
Senior Cancer Researcher
USA
Prof. Vaibhav Sahai
Dept. of Medical Oncology, Hematology,
University of Michigan Health, USA
Dr. André Goy
Chairman and Chief Oncologist
John Theurer Cancer Center, USA
Prof. Ibrahim El Bayoumy
Professor,
Tanta Faculty of Medicine, EGYPT
Prof. Pooja Jain
Professor, Department of Microbiology and Immunology
Drexel University College of Medicine, USA
Prof. Dipali Sharma
Professor, Dept. of Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, USA
Prof. Divij Verma
Dept. of Oncology
Albert Einstein College of Medicine, USA
Prof. Bhagavatula Moorthy
Professor, Dept. of Pediatrics
Baylor College of Medicine, USA
- Track 1: Bladder Cancer
- Track 2: Bone Cancer
- Track 3: Brain Cancer
- Track 4: Breast Cancer
- Track 5: Cancer Genetics & Genomics
- Track 6: Cancer Immunotherapy & Vaccines
- Track 7: Cancer Metabolism
- Track 8: Cell Signalling & Regulation
- Track 9: Cell-Based Therapy
- Track 10: Chemical Biology
- Track 11: Chronic Myeloid Leukemia
- Track 12: Chronic Lymphocytic Leukemia
- Track 13: Developmental Biology
- Track 14: Endocrine Cancer
- Track 15: Epidemiology
- Track 16: Epigenetics
- Track 17: Exercises Oncology
- Track 18: Imaging
- Track 19: Immunology
- Track 20: Lung Cancer
- Track 21: Lymphoma
- Track 22: Palliative Care
- Track 23: Genome Integrity
- Track 24: Gynecologic Cancer
- Track 25: Microbiome & Inflammation
- Track 26: Molecular Pathology & Diagnostics
- Track 27: Multiple Myeloma
- Track 28: Nanotechnology
- Track 29: Neuroscience & Neuro-Oncology
- Track 30: Renal Cell Carcinoma
- Track 31: Sarcoma
- Track 32: Skin Cancer
- Track 33: Side Effect Management
- Track 34: Solid Tumor Oncogenesis
- Track 35: Stem Cells
- Track 36: Structural Biology
- Track 37: Systems Biology
- Track 38: Targeted Therapy
- Track 39: Tumor Micro Environment
- Track 40: Urologic Cancers
- Track 41: Pancreatic Cancer
- Track 42: Pediatric Cancer
- Track 43: Prostate Cancer
- Track 44: Gastrointestinal Cancer
- Track 45: Head & Neck Cancer
- Track 46: Hematologic Malignancies
- Track 47: HPV & Cervical Cancer
- Track 48: Metastasis & Drug Resistance
SUBMIT ABSTRACT
Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should contain sufficient detail on the techniques used and the results, which will be shown. You will receive a confirmation when the abstract has been received. Please contact the conference secretariat if you did not receive confirmation within 5 working days. Submission implies the intent of at least one author to register, attend the symposium and present the paper orally or in poster format. Contributions will only be finally accepted after registration and payment of the conference fee. The abstract will be reviewed, and you will be notified of acceptance.
- The entire body of the abstract, excluding tables, must not exceed 250 words. Spaces are not included in this number. Title, authors’ names, affiliations, figures, and tables are not included in the character count.
- The abstract may be structured (i.e., abstracts divided into sections using terms such as Introduction, Methods, Results, Conclusions, etc.) or unstructured.
- Do not use bold type or underline formatting. Italic type is acceptable.
- Text may be in multiple paragraphs.
- Any references should be noted as citations within the text and not as footnotes at the end
Important Dates
2nd Phase Abstract Submission had been Extended till: 15th January, 2024
Early Bird Registration Closes: 27th February, 2023
Click Here to Submit Abstract
Click Here to Download Brochure
ORGANIZING & SCIENTIFIC COMMITTEE
Padma Shri Dr. Lalit Kumar
Prof & HOD, Dept of Medical Oncology,
AIIMS, INDIA
Padma Shri Dr. Ashok Gupta
Senior Plastic Surgeon,
BHIMS, INDIA
Padma Shri Dr. Ramakant K. Deshpande
Senior Oncologist & Director,
Asian Cancer Institute, INDIA
Dr. G. K. Rath
Chief-Radiation Oncologist,
AIIMS, INDIA
Dr. Shekhar C Mande
Former Director General, CSIR
National President, Vijnana Bharati
Shri Praveen Ramdas
Secretary
Vijnana Bharati, INDIA
Prof. Rajeev Singh
Secretary,
Indraprastha Vigyan Bharati, INDIA
Dr. Raghavendra Rao
Director-CCRYN,
Ministry of AYUSH, INDIA
Dr. Shyam Aggarwal
Senior Medical Oncologist,
Sir Ganga Ram Hospital, INDIA
Dr. Ashok Sharma
Additional Professor,
AIIMS/NCI-Jhajjar, INDIA
Dr. Tarang Krishna
Director,
Cancer Healer Center, INDIA
Dr. Deepika Krishna
Director,
Cancer Healer Center, INDIA